BPG is committed to discovery and dissemination of knowledge
Citation
Wang X, Shi YF, Duan JH, Wang C, Tan HY. S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report. World J Clin Cases 2021; 9(24): 7146-7153 [PMID: 34540971 DOI: 10.12998/wjcc.v9.i24.7146]
Please LOGIN to submit a new comment.